Medpace stock is back below a buy point of 628.92. The medical research contractor delivered an earnings beat for its second quarter. The post Medpace Stock Hovers Near Entry, Offers Second Chance After July Spike appeared first on Investor's Business Daily.
CryptoAlerta — análise de criptomoedas e mercado em tempo real